Ectopic duodenal insulinoma: a very rare and challenging tumor type. Description of a case and review of the literature
- PMID: 24006218
- DOI: 10.1007/s12022-013-9262-y
Ectopic duodenal insulinoma: a very rare and challenging tumor type. Description of a case and review of the literature
Abstract
Although most insulinomas are located in the pancreas, very rare ectopic cases have been described in the spleen, perisplenic tissue, duodenohepatic ligament, and adjacent to the ligament of Treitz. Moreover, three cases located in the duodenum have also been reported in the English literature. Ectopic insulinomas represent challenging neoplasms with clinical implications mainly due to the difficulties in their pre-operatory diagnosis and localization. In the present paper, we describe the fourth ectopic duodenal insulinoma so far reported. A 75-year-old woman presented at clinical observation due to neuroglycopenic symptoms that disappeared after glucose intake. Tumor was localized in the second portion of the duodenum in front of the papilla of Vater and was surgically enucleated. Microscopically, it was composed of monomorphic cells with eosinophilic cytoplasm arranged in trabecular and lobular patterns and diffusely positive for insulin, proinsulin, amylin, and PDX1. About 30 % of tumor cells also showed immunoreactivity for somatostatin, while no positivity for glucagon, pancreatic polypeptide, gastrin, serotonin, and somatostatin receptor subtype 2A was found. The Ki67 proliferative index was 1 %. We have also reviewed the literature on this topic to give the reader a comprehensive overview of this very rare tumor type.
Similar articles
-
Ectopic insulinoma: a systematic review.Rev Endocr Metab Disord. 2023 Dec;24(6):1135-1146. doi: 10.1007/s11154-023-09824-2. Epub 2023 Jul 12. Rev Endocr Metab Disord. 2023. PMID: 37434098
-
Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.Virchows Arch. 2011 Aug;459(2):147-54. doi: 10.1007/s00428-011-1118-6. Epub 2011 Jul 8. Virchows Arch. 2011. PMID: 21739268
-
Extrapancreatic insulinoma.World J Nucl Med. 2020 Jan 17;19(2):162-164. doi: 10.4103/wjnm.WJNM_41_19. eCollection 2020 Apr-Jun. World J Nucl Med. 2020. PMID: 32939209 Free PMC article.
-
Aberrant insulinoma in the duodenum.Gastroenterology. 1986 May;90(5 Pt 1):1280-5. doi: 10.1016/0016-5085(86)90397-5. Gastroenterology. 1986. PMID: 3007262
-
Intraoperative methods to stage and localize pancreatic and duodenal tumors.Ann Oncol. 1999;10 Suppl 4:182-4. Ann Oncol. 1999. PMID: 10436817 Review.
Cited by
-
Ectopic insulinoma: case report.BMC Surg. 2019 Dec 18;19(1):197. doi: 10.1186/s12893-019-0661-y. BMC Surg. 2019. PMID: 31852474 Free PMC article.
-
Successful surgical treatment of a patient with primary insulinoma of the liver.J Surg Case Rep. 2020 Dec 28;2020(12):rjaa519. doi: 10.1093/jscr/rjaa519. eCollection 2020 Dec. J Surg Case Rep. 2020. PMID: 33391648 Free PMC article.
-
The imaging of insulinomas using a radionuclide-labelled molecule of the GLP-1 analogue liraglutide: a new application of liraglutide.PLoS One. 2014 May 7;9(5):e96833. doi: 10.1371/journal.pone.0096833. eCollection 2014. PLoS One. 2014. PMID: 24805918 Free PMC article.
-
Ectopic insulinoma: a systematic review.Rev Endocr Metab Disord. 2023 Dec;24(6):1135-1146. doi: 10.1007/s11154-023-09824-2. Epub 2023 Jul 12. Rev Endocr Metab Disord. 2023. PMID: 37434098
-
Case presentation of 8-year follow up of recurrent malignant duodenal Insulinoma and lymph node metastases and literature review of malignant Insulinoma management.BMC Endocr Disord. 2022 Dec 9;22(1):310. doi: 10.1186/s12902-022-01219-9. BMC Endocr Disord. 2022. PMID: 36494838 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical